Custom Antibody Industry Segmentation, Parameters and Prospects by 2030
The global custom antibody market was valued at USD 147.6 million in 2022 and is projected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030. This growth is largely driven by the rising demand for personalized diagnostic and therapeutic treatments, which has encouraged key market players to invest in new product development, advanced service offerings, and expansion strategies. For example, in January 2023, Creative Biolabs launched a series of services, including therapeutic antibodies, aimed at expanding its therapeutic segment. This move is part of the company’s broader effort to provide comprehensive therapeutic antibody development solutions, enabling it to serve both diagnostic and drug discovery needs more effectively. Similarly, Bio-Rad Laboratories, Inc., in November 2022, introduced the Pioneer Antibody Discovery Platform, a next-generation service designed to accelerate biologic candidate discovery. This platform leverages...